Drugging the undruggable: Yale finds treatment path for muscular dystrophy – Yale News

(© stock.adobe.com)

 
Researchers at Yale have identified a possible treatment for Duchenne muscular dystrophy (DMD), a rare genetic disease for which there is currently no cure or treatment, by targeting an enzyme that had been considered “undruggable.” The finding appears in the Aug. 25 edition of Science Signaling.

DMD is the most common form of muscular dystrophy, a disease that leads to progressive weakness and eventual loss of the skeletal and heart muscles. It occurs in 16 of 100,000 male births in the U.S. People with the disease exhibit clumsiness and weakness in early childhood and typically need wheelchairs by the time they reach their teens. The average life expectancy is 26.

Click here to read full article https://news.yale.edu/2020/09/11/drugging-undruggable-yale-finds-treatment-path-muscular-dystrophy

Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Font Resize